End-of-day quote
Shanghai S.E.
06:00:00 2024-07-04 pm EDT
|
5-day change
|
1st Jan Change
|
22.8
CNY
|
+1.11%
|
|
-1.68%
|
-25.30%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,043
|
6,960
|
4,566
|
5,432
|
3,929
|
-
|
-
|
Enterprise Value (EV)
1 |
6,043
|
6,960
|
4,566
|
5,432
|
3,929
|
3,929
|
3,929
|
P/E ratio
|
28.7
x
|
29.1
x
|
18.5
x
|
41.3
x
|
17.8
x
|
13.5
x
|
11.2
x
|
Yield
|
-
|
1.71%
|
-
|
1.13%
|
2.33%
|
3.24%
|
4.25%
|
Capitalization / Revenue
|
-
|
4.56
x
|
3.08
x
|
4.5
x
|
2.64
x
|
2.15
x
|
1.86
x
|
EV / Revenue
|
-
|
4.56
x
|
3.08
x
|
4.5
x
|
2.64
x
|
2.15
x
|
1.86
x
|
EV / EBITDA
|
-
|
19.7
x
|
12
x
|
18.5
x
|
10.4
x
|
8.05
x
|
6.32
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
2.44
x
|
1.55
x
|
1.86
x
|
1.32
x
|
1.25
x
|
1.17
x
|
Nbr of stocks (in thousands)
|
178,823
|
178,823
|
178,272
|
177,961
|
172,343
|
-
|
-
|
Reference price
2 |
33.80
|
38.92
|
25.61
|
30.52
|
22.80
|
22.80
|
22.80
|
Announcement Date
|
2/25/21
|
2/23/22
|
2/26/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,526
|
1,480
|
1,208
|
1,486
|
1,827
|
2,107
|
EBITDA
1 |
-
|
353.3
|
380
|
294.3
|
379
|
488
|
622
|
EBIT
1 |
-
|
272.3
|
275.5
|
147.4
|
219
|
303
|
397
|
Operating Margin
|
-
|
17.85%
|
18.61%
|
12.2%
|
14.74%
|
16.58%
|
18.84%
|
Earnings before Tax (EBT)
1 |
-
|
271.4
|
272.1
|
146.8
|
219
|
303
|
397
|
Net income
1 |
175.4
|
239.8
|
246.5
|
132.5
|
226.6
|
299.2
|
357
|
Net margin
|
-
|
15.72%
|
16.65%
|
10.97%
|
15.25%
|
16.37%
|
16.94%
|
EPS
2 |
1.177
|
1.338
|
1.385
|
0.7385
|
1.281
|
1.688
|
2.038
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.6672
|
-
|
0.3462
|
0.5308
|
0.7385
|
0.9692
|
Announcement Date
|
2/25/21
|
2/23/22
|
2/26/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
12.8%
|
8.67%
|
8.53%
|
4.49%
|
7.31%
|
9.09%
|
10.4%
|
ROA (Net income/ Total Assets)
|
-
|
7.23%
|
-
|
3.98%
|
5.73%
|
7.4%
|
9.01%
|
Assets
1 |
-
|
3,317
|
-
|
3,332
|
3,955
|
4,043
|
3,962
|
Book Value Per Share
2 |
-
|
16.00
|
16.50
|
16.40
|
17.20
|
18.20
|
19.50
|
Cash Flow per Share
2 |
-
|
1.000
|
1.080
|
2.510
|
2.090
|
2.220
|
2.990
|
Capex
1 |
-
|
406
|
-
|
268
|
274
|
492
|
526
|
Capex / Sales
|
-
|
26.6%
|
-
|
22.18%
|
18.44%
|
26.93%
|
24.96%
|
Announcement Date
|
2/25/21
|
2/23/22
|
2/26/23
|
2/22/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -25.30% | 541M | | +2.09% | 102B | | -11.38% | 59.2B | | +75.24% | 48.89B | | +5.57% | 35.03B | | -1.58% | 30.47B | | +1.46% | 18.26B | | +17.54% | 17.47B | | +6.83% | 13.62B | | +80.76% | 13.18B |
Other Commodity Chemicals
|